Mine & Arao Wealth Creation & Management LLC. Acquires 475 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Mine & Arao Wealth Creation & Management LLC. raised its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 17.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,207 shares of the company’s stock after acquiring an additional 475 shares during the quarter. Mine & Arao Wealth Creation & Management LLC.’s holdings in DocuSign were worth $191,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in shares of DocuSign by 2.4% during the 3rd quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock worth $881,260,000 after buying an additional 482,472 shares in the last quarter. AQR Capital Management LLC grew its position in shares of DocuSign by 147.4% during the 3rd quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock worth $80,157,000 after buying an additional 1,136,948 shares in the last quarter. Jupiter Asset Management Ltd. grew its position in shares of DocuSign by 166.4% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 1,344,703 shares of the company’s stock worth $56,478,000 after buying an additional 839,883 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in DocuSign by 77.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock valued at $51,057,000 after purchasing an additional 531,682 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its position in DocuSign by 32.7% during the third quarter. Robeco Institutional Asset Management B.V. now owns 724,314 shares of the company’s stock valued at $30,421,000 after purchasing an additional 178,299 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

DocuSign Stock Up 1.7 %

Shares of NASDAQ:DOCU traded up $0.95 during trading on Wednesday, hitting $57.55. The stock had a trading volume of 552,764 shares, compared to its average volume of 3,175,017. DocuSign, Inc. has a 12-month low of $38.11 and a 12-month high of $64.76. The stock has a market capitalization of $11.82 billion, a price-to-earnings ratio of 157.50, a price-to-earnings-growth ratio of 4.94 and a beta of 0.89. The stock has a 50-day simple moving average of $56.76 and a two-hundred day simple moving average of $53.03.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The firm had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. As a group, sell-side analysts forecast that DocuSign, Inc. will post 0.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $59.00 price objective on shares of DocuSign in a research report on Friday, April 12th. UBS Group raised DocuSign from a “sell” rating to a “neutral” rating and raised their price objective for the company from $48.00 to $62.00 in a research report on Friday, April 12th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research note on Friday, April 12th. Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $49.00 to $64.00 in a research note on Tuesday, January 16th. Finally, Wells Fargo & Company decreased their price target on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research note on Monday, February 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and a consensus price target of $60.25.

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at $6,847,964.09. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CEO Allan C. Thygesen sold 7,765 shares of DocuSign stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $53.31, for a total transaction of $413,952.15. Following the completion of the transaction, the chief executive officer now directly owns 104,002 shares in the company, valued at $5,544,346.62. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the transaction, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The disclosure for this sale can be found here. Insiders sold a total of 54,871 shares of company stock worth $3,176,199 over the last three months. 17.80% of the stock is currently owned by insiders.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.